|
Volumn 32, Issue 2, 2000, Pages 429-431
|
A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: Long-term results
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
DEXCHLORPHENIRAMINE;
GANCICLOVIR;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE SODIUM SUCCINATE;
OKT 3;
PREDNISOLONE;
THYMOCYTE ANTIBODY;
ACUTE CHOLECYSTITIS;
ARTICLE;
BASAL CELL CARCINOMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS INFECTION;
FEVER;
GLOMERULOPATHY;
GRAFT REJECTION;
HEADACHE;
HUMAN;
HYPERTENSION;
KAPOSI SARCOMA;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOSIS;
TREATMENT OUTCOME;
VOMITING;
ACTUARIAL ANALYSIS;
ANTILYMPHOCYTE SERUM;
DISEASE-FREE SURVIVAL;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
PROSPECTIVE STUDIES;
SURVIVAL RATE;
TIME FACTORS;
|
EID: 0034011133
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)00838-1 Document Type: Article |
Times cited : (7)
|
References (11)
|